Plastid‐Based Production of Recombinant Proteins: Advancing Toward Global Health Applications
Biotechnology Journal · 2026-03 · 21 (3)
DOI: 10.1002/biot.70212 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biotechnology Journal, online erschienen am 12.03.2026. Verfasst von Xuan Zhao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Joint International Research Laboratory of Agriculture and Agri-Product Safety of the Ministry of Education of China, Yangzhou University, Yangzhou, …. Hauptthemen laut MEDLINE: Recombinant Proteins, Plastids. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: Natural Science Foundation of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Plastid‐based production of recombinant proteins has emerged as a transformative platform for global health applications, offering high‐yield, low‐cost, and scalable alternatives to conventional microbial and mammalian systems. Chloroplasts facilitate exceptional transgene expression (often exceeding 40% of total soluble protein (TSP)), due to leveraging high genome copy numbers per cell, precise multi‐gene stacking, minimal position effects, and maternal inheritance for biocontainment. Critically, recent advances have progressed beyond proof‐of‐concept. Edible crops, such as lettuce, have been successfully producing complex human therapeutics, including fully assembled and functional blood coagulation factors, insulin precursors, and antiviral proteins, all of which remain stable and efficacious without the need for purification or cold chain storage. These products meet regulatory standards for bioburden, moisture content, long‐term stability, and batch‐to‐batch consistency, with multiple candidates having received FDA approval to enter human clinical trials. Furthermore, marker‐free engineering strategies have effectively addressed longstanding biosafety concerns, enabling the development of commercial‐grade lines. This review synthesizes these breakthroughs and highlights how plastid technology is being strategically advanced toward equitable, oral‐delivery solutions for vaccines, enzyme replacement therapies, and chronic disease management globally.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Joint International Research Laboratory of Agriculture and Agri-Product Safety of the Ministry of Education of China, Yangzhou University, Yangzhou, China.
- College of Bioscience and Biotechnology, Yangzhou University, Yangzhou, China.
ORCID-Profile: Xueyun Hu
Förderung
- Natural Science Foundation of China
- National Natural Science Foundation of China
Zitieren
APA
Zhao, X., Jia, T., & Hu, X. (2026). Plastid‐Based Production of Recombinant Proteins: Advancing Toward Global Health Applications. Biotechnology Journal, 21(3). https://doi.org/10.1002/biot.70212
Vancouver
Zhao X, Jia T, Hu X. Plastid‐Based Production of Recombinant Proteins: Advancing Toward Global Health Applications. Biotechnology Journal. 2026;21(3). doi:10.1002/biot.70212
BibTeX
@article{Zhao2026,
author = {Zhao, Xuan and Jia, Ting and Hu, Xueyun},
title = {Plastid‐Based Production of Recombinant Proteins: Advancing Toward Global Health Applications},
journal = {Biotechnology Journal},
year = {2026},
volume = {21},
number = {3},
doi = {10.1002/biot.70212}
}
EUVIMED